Moderna starts human trials for Bundibugyo Ebola vaccine as Congo's outbreak continuesModerna has initiated Phase 1 human trials for a Bundibugyo Ebola vaccine in Canada, using its mRNA technology similar to its COVID-19 vaccine. The trial involves approximately 80 volunteers to assess safety, tolerance, and immune response against the Bundibugyo strain, which currently lacks a vaccine. This comes as the Democratic Republic of Congo experiences its second-largest Ebola outbreak, with over 3,800 cases and 1,700 deaths reported. Public health officials warn that community transmission is outpacing traditional contact tracing methods, raising concerns about the outbreak's trajectory. CEPI, a global partnership focused on epidemic preparedness, supports multiple vaccine candidates, including those from Moderna and the University of Oxford, aiming to accelerate vaccine development.
Bias read (Center): The article presents information about a scientific and medical development without overtly favoring any political ideology. While the topic relates to public health and international cooperation, the framing remains neutral, focusing on factual updates and expert commentary without ideological slan
WHO calls for more support to tackle Ebola outbreakThe World Health Organization (WHO) has urged increased support to address the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC), stating that current efforts are insufficient to contain the spread of the disease. According to WHO spokesperson Tarik Jasarevic, the outbreak continues to expand beyond existing response capacities, necessitating additional financial and resource support for treatment, field investigations, safe burials, and community engagement. As of April 2026, the DRC has reported 3,802 confirmed cases, including 1,707 deaths, with most cases concentrated in the northeastern province of Ituri. The outbreak, caused by the Bundibugyo strain of Ebola, lacks proven treatments or vaccines, though several therapeutic and preventive trials are underway. WHO experts note that early results from these trials show promise.
Bias read (Center): The article presents factual information about the Ebola outbreak and WHO's call for increased support without overtly favoring any political ideology. While the situation involves governmental responsibility and international health coordination, the framing remains neutral, focusing on medical and
European Union
